Epoetin Beta in Patients Undergoing Chemotherapy for Solid Tumors
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Epoetin beta may cause the body to make more red blood cells and may prevent or
reduce side effects in patients undergoing chemotherapy for solid tumors.
PURPOSE: This clinical trial is studying how well epoetin beta works in patients undergoing
chemotherapy for solid tumors.